Stock Comparison

BBIO vs VRTX

BridgeBio Pharma Inc and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

BBIO

BridgeBio Pharma Inc

Healthcare

VRTX

Vertex Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$13.76B

$124.70B

P/E (TTM)

—

29.2

Forward P/E

—

25.8

Price/Sales

23.7

10.2

Price/Book

123.7

6.4

EV/EBITDA

-9.4

24.0

Dividend Yield

—

Profitability

Net Margin

-124.40%

35.50%

Operating Margin

-54.50%

38.10%

Return on Equity

-1790.00%

24.20%

Return on Assets

-28.00%

12.10%

Growth (YoY)

Revenue Growth

66.80%

7.80%

Earnings Growth

0.00%

61.40%

Price & Risk

Beta

1.0

0.3

52-Week High

$84.94

$507.92

52-Week Low

$41.80

$362.50

Analyst Target

$102.28

$548.69

Compare BBIO and VRTX your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.